An open label, randomised, parallel group clinical study to evaluate the effect of the Connected Inhaler System (CIS) on adherence to Relvar/Breo ELLIPTA therapy, in asthmatic subjects with poor control.
Phase of Trial: Phase IV
Latest Information Update: 19 Feb 2019
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 19 Feb 2019 This trial has been completed in Germany (End date: 2019-01-24), according to the European Clinical Trials Database record
- 02 Feb 2019 This trial has been completed in Spain, according to the European Clinical Trials Database record.
- 31 Aug 2018 Biomarkers information updated